Bionano Genomics, Inc.
BNGO · Laboratory Analytical Instruments
Latest available SEC filing: 4 ·
Latest disclosures
-
Luderer Albert: Form 4
Insider disclosure · Filed · Report period 04 Sep 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001411690 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- BNGO on Nasdaq
- SEC industry group
- Laboratory Analytical Instruments (Industrial Applications and Services)
- Business address
- 9540 Towne Centre Drive, Suite 100, San Diego, CA, 92121
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- BioNanomatrix Inc (to 24 Mar 2011)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields